跳至主要内容
临床试验/NCT04829838
NCT04829838Unknown4 期

Comparison of Efficacy of Phenytoin With Levetireacetam for the Management of Children With Status Epilepticus

ayesha tariq1 个研究点 分布在 1 个国家目标入组 244 人开始时间: 2019年7月25日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
244
试验地点
1
主要终点
comparison of efficacy of levetireacetam with phenytoin for the management of children with status epilepticus

研究概览

简要总结

The purpose of studyis to compare the efficacy of phenytoin with levetiracetam for the management of children with status epilepticus.Study performa consists of demographic variables,exclusion criteria,history of epilepsy and efficacy achieved or not.

详细描述

After getting informed consent 244 children with status epilepticus will be randomly classified into two groups.one group will receive levetireacetam and other group will be given phenytoin and their efficacy will be compared by observing them for breakthrough fits for next 48 hours.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
2 Months 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • childen of age less than 12 years either gender admitted in pediatric emergency with status epilepticus

排除标准

  • children already taking either of trial drug or failed treatment with either of trial drug.children with comorbid conditions

研究组 & 干预措施

Intravenous levetireacetam

Experimental

Drug:Intravenous levetireacetam will be given at a loading dose of 20-30mg/kg then it will be added in maintainance dose of (5-30mg/kg/day)

干预措施: intravenous levetireacetam (Drug)

intravenous phenytoin

Experimental

Intravenous phenytoin will be given in loading dose of 20mg/kg then it will be added in maintainance dose i-e 5-8mg/kg/day

干预措施: intravenous levetireacetam (Drug)

结局指标

主要结局

comparison of efficacy of levetireacetam with phenytoin for the management of children with status epilepticus

时间窗: 48 hours

the intervention will be considered efficacious if child will not have breakthrough fits for 48 hours

次要结局

未报告次要终点

研究者

发起方
ayesha tariq
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

ayesha tariq

Post graduate resident in Pediatrics medicine(MD Paeds)

King Edward Medical University

研究点 (1)

Loading locations...

相似试验